Savara Inc.

SVRANASDAQUSD
5.34 USD
0.04 (0.76%)AT CLOSE (11:59 AM EDT)
5.50
0.16 (3.07%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
5.50
0.16 (3.07%)
🔴Market: CLOSED

Savara Inc. (SVRA) trades at $5.34 per share. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. SVRA is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Sep 14, 2026.

Open?$5.33
High?$5.43
Low?$5.28
Prev. Close?$5.30
Volume?1.3M
Avg. Volume?1.5M
VWAP?$5.36
Rel. Volume?0.89x
Bid / Ask
Bid?$4.54 × 100
Ask?$6.38 × 100
Spread?$1.84
Midpoint?$5.46
Valuation & Ratios
Market Cap?1.1B
Shares Out?205.5M
Float?146.5M
Float %?71.5%
P/E Ratio?N/A
P/B Ratio?7.58
EPS?-$0.68
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
Employees
70
Market Cap
1.1B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
1996-11-18
Address
6836 BEE CAVE ROAD
AUSTIN, TX 78746
Phone: 51285113796
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-3/3)
Medium-Term (Wave)? Bearish(-2/3)
Short-Term (Ripple)? Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
5
Piotroski F-Score?0/9Weak
Altman Z-Score?7.02Safe
Confidence?48%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?28.29%Squeeze Risk
Short Interest?41.4M
Days to Cover?24.3
Free Float146.5M
Avg Daily Volume1.7M
Settlement Date2026-08-31
Financial Health
Current Ratio?10.13Strong
Quick Ratio?10.13Strong
Cash Ratio?2.38Strong
Debt/Equity?0.21Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A
P/B?
Peers
100
S&P
25
7.58FAIR
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
S&P
97
-7.5CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
S&P
3
-97.0%WEAK
ROA?
S&P
3
-72.5%WEAK
Cash Flow & Enterprise
FCF?$-110660000
Enterprise Value?$1.1B
Fundamentals ratios updated end of day